Immune microenvironment dysfunctions enable malignification at the onset of myelodysplastic syndromes
Year: 2022
Type: conference-paper
Abstract: Myelodysplastic syndromes (MDS): clonal stem cell malignancies • Standard therapy not curative, transient responses, poor prognosis • Are prevention or early intervention possible in MDS? • Clonal cytopenias of undetermined significance (CCUS): aging-related premalignant state, low-grade clonal hematologic disorders at high risk of progression to MDS and leukemia • HSC-intrinsic alterations and extrinsic inflammatory factors cooperate to induce abnormal differentiation in CCUS (Ganan-Gomez et al.ASH Meeting 2021).
DOI: 10.52519/00055
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4313159664
